Skip to main content
. 2022 Apr 16;2022:2967977. doi: 10.1155/2022/2967977

Table 2.

Daily dietary intake of participants during the trial (mean ± SD).

Variables Mean ± SD p value2 p value3
Synbiotics (n = 52) Placebo (n = 56)
Energy (kcal) Baseline 1963.75 ± 437.99 1903.82 ± 368.23 0.578
At 12 wk 1443.86 ± 290.36 1526.90 ± 440.42 0.382
p value1 <0.001 <0.001 0.21

Protein (g) Baseline 73.27 ± 27.69 70.95 ± 17.95 0.702
At 12 wk 55.13 ± 24.10 64.10 ± 20.68 0.137
p value1 0.02 0.11 0.16

Fat (g) Baseline 80.09 ± 32.18 77.22 ± 24.23 0.703
At 12 wk 51.74 ± 8.79 54.99 ± 23.43 0.578
p value1 <0.001 0.001 0.49

Carbohydrate (g) Baseline 242.38 ± 56.58 237.52 ± 58.43 0.755
At 12 wk 188.53 ± 50.42 195.78 ± 62.46 0.642
p value1 <0.001 <0.001 0.36

Glucose (g) Baseline 54.49 ± 18.28 59.75 ± 19.59 0.308
At 12 wk 33.70 ± 16.43 35.21 ± 22.73 0.783
p value1 <0.001 <0.001 0.59

p value1: significance of within-group alterations (paired t-test); p value2: significance of between-group alterations (independent t-test); p value3: treatment by analysis of covariance (adjusted baseline variable).